Flavio Maina - Search Results

Year	Number of Results
2003	1
2004	1
2005	4
2006	3
2007	4
2008	1
2009	1
2010	2
2011	5
2012	5
2013	2
2014	3
2015	2
2016	1
2017	1
2018	4
2019	3
2020	6
2021	6
2022	3
2023	1
2024	0

1

Turning up our understanding of liver cancer by a notch.

Lujambio A, Maina F. Lujambio A, et al. Among authors: maina f. J Hepatol. 2021 Mar;74(3):502-504. doi: 10.1016/j.jhep.2020.10.027. Epub 2020 Dec 17. J Hepatol. 2021. PMID: 33342548 No abstract available.

2

Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response.

Sequera C, Maina F. Sequera C, et al. Among authors: maina f. Hepatobiliary Surg Nutr. 2022 Feb;11(1):139-142. doi: 10.21037/hbsn-21-517. Hepatobiliary Surg Nutr. 2022. PMID: 35284507 Free PMC article. No abstract available.

3

MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

Sequera C, Grattarola M, Holczbauer A, Dono R, Pizzimenti S, Barrera G, Wangensteen KJ, Maina F. Sequera C, et al. Among authors: maina f. Cell Death Dis. 2022 Nov 24;13(11):994. doi: 10.1038/s41419-022-05411-6. Cell Death Dis. 2022. PMID: 36433941 Free PMC article.

4

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.

Arechederra M, Bazai SK, Abdouni A, Sequera C, Mead TJ, Richelme S, Daian F, Audebert S, Dono R, Lozano A, Gregoire D, Hibner U, Allende DS, Apte SS, Maina F. Arechederra M, et al. Among authors: maina f. J Hepatol. 2021 Apr;74(4):893-906. doi: 10.1016/j.jhep.2020.11.008. Epub 2020 Nov 13. J Hepatol. 2021. PMID: 33197513

5

Liver Cancer Gene Discovery Using Gene Targeting, Sleeping Beauty, and CRISPR/Cas9.

Kieckhaefer JE, Maina F, Wells RG, Wangensteen KJ. Kieckhaefer JE, et al. Among authors: maina f. Semin Liver Dis. 2019 May;39(2):261-274. doi: 10.1055/s-0039-1678725. Epub 2019 Mar 25. Semin Liver Dis. 2019. PMID: 30912094 Free PMC article. Review.

6

Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Rada P, Lamballe F, Carceller-López E, Hitos AB, Sequera C, Maina F, Valverde ÁM. Rada P, et al. Among authors: maina f. Cells. 2022 Feb 24;11(5):793. doi: 10.3390/cells11050793. Cells. 2022. PMID: 35269415 Free PMC article.

7

Strategies to overcome drug resistance of receptor tyrosine kinaseaddicted cancer cells.

Maina F. Maina F. Curr Med Chem. 2014;21(14):1607-17. doi: 10.2174/09298673113209990222. Curr Med Chem. 2014. PMID: 23992334 Review.

8

The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC.

Khera L, Vinik Y, Maina F, Lev S. Khera L, et al. Among authors: maina f. Life Sci Alliance. 2021 Mar 30;4(6):e202000985. doi: 10.26508/lsa.202000985. Print 2021 Jun. Life Sci Alliance. 2021. PMID: 33785524 Free PMC article.

9

Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing.

Legier T, Rattier D, Llewellyn J, Vannier T, Sorre B, Maina F, Dono R. Legier T, et al. Among authors: maina f. Nat Commun. 2023 Jan 21;14(1):349. doi: 10.1038/s41467-023-35965-8. Nat Commun. 2023. PMID: 36681697 Free PMC article.

10

Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis.

Verma N, Vinik Y, Saroha A, Nair NU, Ruppin E, Mills G, Karn T, Dubey V, Khera L, Raj H, Maina F, Lev S. Verma N, et al. Among authors: maina f. Sci Adv. 2020 Aug 21;6(34):eaba8968. doi: 10.1126/sciadv.aba8968. Print 2020 Aug. Sci Adv. 2020. PMID: 32937365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year